These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 29562529)

  • 1. Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
    Griñán-Ferré C; Corpas R; Puigoriol-Illamola D; Palomera-Ávalos V; Sanfeliu C; Pallàs M
    J Alzheimers Dis; 2018; 62(3):943-963. PubMed ID: 29562529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HDAC6 in Alzheimer's disease.
    Zhang L; Sheng S; Qin C
    J Alzheimers Dis; 2013; 33(2):283-95. PubMed ID: 22936009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics of Alzheimer's disease and frontotemporal dementia.
    Veerappan CS; Sleiman S; Coppola G
    Neurotherapeutics; 2013 Oct; 10(4):709-21. PubMed ID: 24150812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in neurodegeneration: a new layer of complexity.
    Marques SC; Oliveira CR; Pereira CM; Outeiro TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):348-55. PubMed ID: 20736041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: the quest to understand complexity.
    Marques SC; Oliveira CR; Outeiro TF; Pereira CM
    J Alzheimers Dis; 2010; 21(2):373-83. PubMed ID: 20555132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice.
    Bayod S; Felice P; Andrés P; Rosa P; Camins A; Pallàs M; Canudas AM
    Neurobiol Aging; 2015 Feb; 36(2):720-9. PubMed ID: 25443287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice.
    Vasilopoulou F; Bellver-Sanchis A; Companys-Alemany J; Jarne-Ferrer J; Irisarri A; Palomera-Ávalos V; Gonzalez-Castillo C; Ortuño-Sahagún D; Sanfeliu C; Pallàs M; Griñán-Ferré C
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
    Qazi TJ; Quan Z; Mir A; Qing H
    Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging epigenetics in Alzheimer's disease.
    Lista S; Garaci FG; Toschi N; Hampel H
    Curr Pharm Des; 2013; 19(36):6393-415. PubMed ID: 23432717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroepigenetics and Alzheimer's Disease: An Update.
    Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
    J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review).
    Li X; Bao X; Wang R
    Mol Med Rep; 2016 Aug; 14(2):1043-53. PubMed ID: 27314984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
    De Plano LM; Saitta A; Oddo S; Caccamo A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in Alzheimer's Disease: A Critical Overview.
    Villa C; Combi R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape.
    Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M
    Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.